Background: Variability in cardiovascular drugs is of great interest because of its high population use, its high expenditure and the availability of strong evidence supporting its use. The aim of this study is to describe variation in dispensation, price and pharmaceutical expenditure for 11 subgroups of cardiovascular drugs by healthcare areas.
Methods: This was a population study describing dispensation for 11 subgroups of cardiovascular drugs among healthcare areas in 2005.